ஜு மைக்கேல் பிஷப் நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜு மைக்கேல் பிஷப் நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜு மைக்கேல் பிஷப் நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி Today - Breaking & Trending Today

Anticancer Biosciences is developing a new antimitotic cancer therapeutics using natural products


Chengdu, China (PRUnderground) March 1st, 2021
Anticancer Biosciences is applying its synthetic lethality expertise for better cancer therapies. The identification of novel antimitotic agents that do not lead to severe side effects is much significant in the present day oncology drug development. At the J. Michael Bishop Institute of Cancer Research (MBICR), China’s world-leading cancer research Centre, there are many advanced research initiatives in this context.
A recently published study from our Natural Product Drug Discovery Group (NPDD) highlights a novel screening method in uncovering the next generation of antimitotic natural compounds. The study, entitled ‘Purification, identification, and characterization of two benzophenanthridine alkaloids from Corydalis longicalcarata rhizomes with anti-mitotic and polyploidy-inducing activities’, was published in “Phytochemistry Letters”, an Official Journal of the Phytochemical Society of Europe, on 7th January 20 ....

Jing Zhang , J Michael Bishop , Jinhua Li , J Michael Bishop Institute Of Cancer Research , Journal Of The Phytochemical Society Europe , Natural Product Drug Discovery Group , Anticancer Bioscience Ltd , Anticancer Biosciences , Bishop Institute , Cancer Research , Official Journal , Phytochemical Society , Anticancer Bioscience , Dun Yang , Michael Bishop Institute , New Antimitotic Cancer Therapeutics , Natural Products , ஜிங் ஜாங் , ஜு மைக்கேல் பிஷப் , ஜின்ஹுவா லி , ஜு மைக்கேல் பிஷப் நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி , இயற்கை ப்ராடக்ட் மருந்து கண்டுபிடிப்பு குழு , பிஷப் நிறுவனம் , புற்றுநோய் ஆராய்ச்சி , அதிகாரி இதழ் , டன் யாங் ,

Anticancer Bioscience Announces CNY63m (~USD10m) Financing to Advance its Synthetic Lethal Platform and Pre-clinical Oncology Pipeline


Press release content from Business Wire. The AP news staff was not involved in its creation.
Anticancer Bioscience Announces CNY63m (~USD10m) Financing to Advance its Synthetic Lethal Platform and Pre-clinical Oncology Pipeline
February 8, 2021 GMT
CHENGDU, China (BUSINESS WIRE) Feb 8, 2021
Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today that having successfully closed an additional financing round, raising CNY63m (~USD10m), it has already achieved positive animal data in its small molecule program targeting MYC overexpression.
The financing, by a small syndicate of undisclosed, experienced Chinese angel investors adds to the previous seed financing of CNT68.75m (~USD11m) and is being used to support further expansion of ACB’s proprietary screening libraries and discovery platforms, with the goal of progressing two of its programs towards IND enabling studies this year. ....

Andhra Pradesh , United States , United Kingdom , San Francisco , Sue Charles , J Michael Bishop , Scius Communications , J Michael Bishop Institute Of Cancer Research , Bishop Institute , Dun Yang , Chengdu China , Anticancer Bioscience , Business Wire , Medical Research , Greater China , Social Affairs , North America , Diseases And Conditions , South Asia , East Asia , ஆந்திரா பிரதேஷ் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , சான் பிரான்சிஸ்கோ , வழக்கு சார்லஸ் , ஜு மைக்கேல் பிஷப் ,

Reportable, Inc.: Anticancer Bioscience Presenting at Biotech Showcase Digital 2021 Showcasing its Synthetic Lethal Precision Oncology Pipeline for the First Time


Reportable, Inc.: Anticancer Bioscience Presenting at Biotech Showcase Digital 2021 Showcasing its Synthetic Lethal Precision Oncology Pipeline for the First Time
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
Anticancer Bioscience is participating in Biotech Showcase Digital 2021.
The Company will showcase its pioneering approach to precision oncology, and how it is applying its synthetic lethality expertise for better cancer therapies.
The Company has five distinct synthetic lethality programs in drug development.
Click image above to view full announcement.
About Anticancer Bioscience - https://www.anticancerbio.com/
Anticancer Bioscience (ACB) is an international private company, commercialising discoveries emerging from China s world-leading cancer research at the J. Michael Bishop Institute of Cancer Research. Pioneers in synthetic lethal approaches to precision o ....

United States , Andhra Pradesh , United Kingdom , San Francisco , Kostenloser Wertpapierhandel , J Michael Bishop , Sue Charles , J Michael Bishop Institute Of Cancer Research , China Newsfile Corp , Showcase Digital , Biotech Showcase Digital , Anticancer Bioscience , Bishop Institute , Dun Yang , Anti Cancer , ஒன்றுபட்டது மாநிலங்களில் , ஆந்திரா பிரதேஷ் , ஒன்றுபட்டது கிஂக்டம் , சான் பிரான்சிஸ்கோ , ஜு மைக்கேல் பிஷப் , வழக்கு சார்லஸ் , ஜு மைக்கேல் பிஷப் நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி , காட்சி பெட்டி டிஜிட்டல் , பயோடெக் காட்சி பெட்டி டிஜிட்டல் , பிஷப் நிறுவனம் , டன் யாங் ,